Sonedenoson, formerly known as MRE0094, is an adenosine A2A receptor agonist, which can effectively promote rapid wound healing. By stimulating adenosine A2A receptor, Sonedenoson increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. References: Mantell S, Jones R, Trevethick M. Design and application of locally delivered agonists of the adenosine A(2A) receptor. Expert Rev Clin Pharmacol. 2010 Jan;3(1):55-72. doi: 10.1586/ecp.09.57. PubMed PMID: 22111533.

纯度：≥98%

CAS：131865-88-8